Tucatinib Alternatives Compared
Tucatinib | Ribociclib | Piqray |
|
---|
Tucatinib | Ribociclib | Piqray (alpelisib) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Breast Cancer, Colorectal Cancer. tucatinib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer. ribociclib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer, Breast Cancer - Male. Piqray may also be used for purposes not listed in this medication guide. |
||||||||
More about Tucatinib | More about Ribociclib | More about Piqray (alpelisib) | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Ribociclib has an average rating of 8.3 out of 10 from a total of 29 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 8% reported a negative effect. |
Piqray has an average rating of 6.3 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: tucatinib side effects in more detail. |
See also: ribociclib side effects in more detail. |
See also: Piqray side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Piqray prices |
||||||||
Dosage Form(s) Available | ||||||||||
N/A |
N/A |
|
||||||||
Brand Names | ||||||||||
Tukysa | Kisqali | Other alpelisib brands include: Vijoice | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
8.5 hours |
54.7 hours |
9 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 491 drugs are known to interact with tucatinib:
|
A total of 708 drugs are known to interact with ribociclib:
|
A total of 313 drugs are known to interact with Piqray:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
April 17, 2020 |
March 13, 2017 |
May 24, 2019 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.